Companies
Codex Genetics
runs a clinical metagenomic whole-genome-sequencing platform with dedicated gastroenterological, gastric and metabolic diagnostic panels for clinical use.
- Country
- United States
Commercial
Metagenomic WGS / CoGenesis panels
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $41,300 total funding | prospeo.io |
| Headcount | 11-20 employees | prospeo.io · codexgenetics.com |
| Revenue | $1,283,325 annual revenue | prospeo.io |
| Production site | Hong Kong Science Park, Hong Kong | codexgenetics.com · ncbi.nlm.nih.gov |
| Certification | ISO 15189, ISO 27001, GenQA/UK NEQAS accredited | codexgenetics.com |
Independent sources: ncbi.nlm.nih.gov · prospeo.io
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Microbiome diagnostic panels | diagnostics-medtech | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.